Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05143840
Title Asciminib as Initial Therapy for Patients With Chronic Myeloid Leukemia in Chronic Phase
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Augusta University
Indications

chronic myeloid leukemia

Therapies

Asciminib

Asciminib + Nilotinib

Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Georgia Cancer Center at Augusta University Not yet recruiting Augusta Georgia 30912 United States Details
Froedtert Hospital & the Medical College of Wisconsin Recruiting Milwaukee Wisconsin 53226 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field